Basel, Switzerland

Joseph Schoepfer

This inventor holds 1 USPTO granted patent. Top assignee: Suzhou Novartis Technical Development Co., Ltd.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Joseph Schoepfer. Retrieved from https://idiyas.com/inventor/joseph-schoepfer-jkfd6rsx

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 1.0


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Joseph Schoepfer: Innovator in Pharmaceutical Compounds

Introduction

Joseph Schoepfer is a notable inventor based in Basel, Switzerland. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on chemical compounds.

Latest Patents

Joseph Schoepfer holds a patent for the invention titled "7-oxo-[1,2,4]triazolo[1,5-a]pyrimidin-4(7H)-yl) Compounds and Uses Thereof." This patent reflects his expertise in developing novel compounds that may have various applications in medicine.

Career Highlights

Currently, Joseph Schoepfer is employed at Suzhou Novartis Technical Development Co., Ltd. His role at this prominent company allows him to further his research and development efforts in the pharmaceutical industry.

Collaborations

Throughout his career, Joseph has collaborated with talented individuals such as Vincent Bordas and Jvan Brun. These partnerships have likely contributed to the success of his projects and innovations.

Conclusion

Joseph Schoepfer is a distinguished inventor whose work in pharmaceutical compounds has the potential to impact the industry significantly. His contributions, including his patent and collaborations, highlight his commitment to innovation in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…